(Q45722312)

English

Recombinant vaccinia virus expressing IL-2 generates effective anti-tumor responses in an orthotopic murine model of head and neck carcinoma

scientific article published in August 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Recombinant vaccinia virus expressing IL-2 generates effective anti-tumor responses in an orthotopic murine model of head and neck carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Bert W. O'Malley

4

object named as

Bert O'Malley

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Santanu Dasgupta

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Pulak K Tripathi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Malaya Bhattacharya-Chatterjee

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sunil K Chatterjee

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

238-248

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel therapeutics for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2: clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukins and contrasuppression induce immune regression of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 receptors on squamous cell carcinomas of the head and neck. Characterization and functional role

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproliferative effects of cytokines on squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunology of head and neck cancer: perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A biologic assay for IL-4. Rapid fluorescence assay for IL-4 detection in supernatants and serum

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new immunocompetent murine model for oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900148-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1525-0016(03)00148-5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45722312&oldid=2100271008"